Background: Intensive care unit-acquired muscle weakness (ICUAW) has an incidence of 40-46%. Early mobilisation is known to be a protective factor.
Objective: The aim of the study was to identify the incidence of ICUAW in Spain and to evaluate variables likely to contribute to the development of ICUAW.
Methods: A 4-month, prospective observational multicentre cohort study was conducted on patients receiving invasive mechanical ventilation for at least 48 h. Data were collected from ICU day 3 until ICU discharge. The primary outcome was presence of ICUAW (diagnosed using the Medical Research Council [MRC] scale). The secondary outcome was nurse-patient ratio, physiotherapist availability, analgesia, sedation and delirium management, glycaemic control, and daily level of mobility during the ICU stay as per the ICU Mobility Scale. A logistic regression model was constructed based exclusively on days 3-5 of the ICU stay.
Results: The data of 642 patients were analysed from 80 ICUs, accounting for 35% of all ICUs in Spain. The incidence of ICUAW was 58% (275 of 474 patients; 95% confidence interval [CI] [53-62]). The predictors for ICUAW were older age (odds ratio [OR] = 1.01; 95% CI [1.00-1.03]) and more days with renal replacement therapy (OR = 1.01; 95% CI [1.00-1.02]). The protective factors for ICUAW were male gender (OR = 0.58; 95% CI [0.38-0.89]), higher Barthel Index (showing prehospital functional independence) (OR = 0.97; 95% CI [0.95-0.99]), more days of being awake and cooperative (defined by a feasible MRC assessment) (OR = 0.98; 95% CI [0.97-0.99]), presence of delirium (OR = 0.98; 95% CI [0.97-0.99]), and more days with active mobilisation (ICU Mobility Scale ≥ 4) (OR = 0.98; 95% CI [0.97-0.99]).
Conclusions: The risk factors for ICUAW were functional dependence before admission, female gender, older age, and more days on renal replacement therapy. The protective factors for ICUAW were feasibility of MRC assessment, the presence of delirium, and being actively mobilised during the first 5 days in the ICU.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.aucc.2020.12.005 | DOI Listing |
BMC Neurol
December 2024
The First School of Clinical Medicine, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
Background: ICU-acquired weakness (ICU-AW) is a common complication among ICU patients. We used machine learning techniques to construct an ICU-AW inflammatory factor prediction model to predict the risk of disease development and reduce the incidence of ICU-AW.
Methods: The least absolute shrinkage and selection operator (LASSO) technique was used to screen key variables related to ICU-AW.
World J Clin Cases
December 2024
Department of Clinical Pharmacy, Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563006, Guizhou Province, China.
This editorial discusses an article recently published in the , focusing on risk factors associated with intensive care unit-acquired weakness (ICU-AW). ICU-AW is a serious neuromuscular complication seen in critically ill patients, characterized by muscle dysfunction, weakness, and sensory impairments. Post-discharge, patients may encounter various obstacles impacting their quality of life.
View Article and Find Full Text PDFAnn Intensive Care
November 2024
Department of Neurology, Schoen Clinic Bad Aibling, Research Group, Kolbermoorer Strasse 72, 83043, Bad Aibling, Germany.
Background: Critical illness survivors frequently suffer from long-term impairments, often described as post-intensive care syndrome (PICS). PICS encompasses physical, cognitive, and mental impairments. Additionally, the term intensive care unit (ICU)-acquired weakness (ICUAW) was coined for muscle weakness after critical illness.
View Article and Find Full Text PDFNeurosci Lett
October 2023
Department of Statistics, College of Mathematics and Statistics, Shandong University, Weihai, Shandong 264209, China. Electronic address:
Background: Intensive care unit-acquired weakness (ICU-AW) is a prevalent and severe neuromuscular complication in critically ill patients. It is a consequence of critical illness and is characterized by systemic inflammatory response syndrome (SIRS)-induced metabolic stress and multiple organ dysfunctions. Moreover, ICU-AW is one of the most important factors affecting the prognosis of patients with SIRS, Electrophysiological examination is an effective method for early identification and monitoring of the course of the disease and is essential for accurate diagnosis of critical illness neuromyopathy (CINM).
View Article and Find Full Text PDFJ Intensive Care
September 2024
Departamento Ciencias de la Rehabilitación, Facultad de Medicina, Universidad de La Frontera, Claro Solar 115, Temuco, Chile.
Rationale: Intensive care unit-acquired weakness (ICUAW) is common in critically ill patients, characterized by muscle weakness and physical function loss. Determining risk factors for ICUAW poses challenges due to variations in assessment methods and limited generalizability of results from specific populations, the existing literature on these risk factors lacks a clear and comprehensive synthesis.
Objective: This overview aimed to synthesize risk factors for ICUAW, categorizing its modifiable and nonmodifiable factors.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!